Guideline manuscript template conformation to reporting checklists
Domain . | GIN-McMaster checklist (step) . | RIGHT (topic) . | AGREE II (item) . | Guideline manuscript template (page)* . |
---|---|---|---|---|
Basic information | ||||
Title | — | 1 | — | 1 |
Authors | 15.3 | — | — | 1 |
Abstract | — | — | — | 2 |
Executive summary | — | 2 | 17 | 3 |
Abbreviations and acronyms | — | 3 | — | 1 |
Corresponding developer | — | 4 | — | 1 |
Background | ||||
Brief description of the health problem | 2.9 | 5 | — | 6 |
Aims of the guideline and specific objectives | 2.2 | 6 | 1 | 6 |
Target populations | 8.3, 8.7 | 7 | 2 & 3 | 6 |
End users and settings | 5 | 8 | 6 | 6 |
Guideline development groups | 3 | 9 | 4 | 7 |
Evidence | ||||
Health care questions | 8 | 10 | 2 | 9 |
Systematic reviews | 10, 11 | 11 | 7, 8 | 9 |
Assessment of the certainty of the body of evidence | 12 | 12 | 9 | 10 |
Recommendations | ||||
Recommendations | 13 & 14 | 13 | 10, 11, 15, 16, 20 | 13 |
Rationale for recommendations | 13.6 | 14 | 5, 12, 20 | 13 |
Evidence to decision process | 13.1 | 15 | 10, 12 | 9 |
Review and quality assurance | ||||
External review | 15.7, 15.8 | 16 | 13 | 12 |
Quality assurance | 15.6 | 17 | — | 12 |
Funding and declaration and management of interests | ||||
Funding sources and roles of the funder | 7.6 | 18 | 22 | 7 |
Declaration and management of interests | 7 | 19 | 23 | 7 |
Other information | ||||
Access | 16.1 | 20 | — | Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) |
Suggestions for further research | 13.5 | 21 | — | Each recommendation (EtD) |
Limitations of the guideline | — | 22 | — | 15 |
Updating the guideline | 18 | — | 14 | 16 |
Applicability | 14.5 | 14 | 14 | Whole document (eg, feasibility, barriers for each recommendation) |
Implementation | 16 | — | 18, 19 | Each recommendation (EtD) & 16 (local adaptation) |
Monitoring | 17.3 | — | 21 | Each recommendation (EtD) |
Domain . | GIN-McMaster checklist (step) . | RIGHT (topic) . | AGREE II (item) . | Guideline manuscript template (page)* . |
---|---|---|---|---|
Basic information | ||||
Title | — | 1 | — | 1 |
Authors | 15.3 | — | — | 1 |
Abstract | — | — | — | 2 |
Executive summary | — | 2 | 17 | 3 |
Abbreviations and acronyms | — | 3 | — | 1 |
Corresponding developer | — | 4 | — | 1 |
Background | ||||
Brief description of the health problem | 2.9 | 5 | — | 6 |
Aims of the guideline and specific objectives | 2.2 | 6 | 1 | 6 |
Target populations | 8.3, 8.7 | 7 | 2 & 3 | 6 |
End users and settings | 5 | 8 | 6 | 6 |
Guideline development groups | 3 | 9 | 4 | 7 |
Evidence | ||||
Health care questions | 8 | 10 | 2 | 9 |
Systematic reviews | 10, 11 | 11 | 7, 8 | 9 |
Assessment of the certainty of the body of evidence | 12 | 12 | 9 | 10 |
Recommendations | ||||
Recommendations | 13 & 14 | 13 | 10, 11, 15, 16, 20 | 13 |
Rationale for recommendations | 13.6 | 14 | 5, 12, 20 | 13 |
Evidence to decision process | 13.1 | 15 | 10, 12 | 9 |
Review and quality assurance | ||||
External review | 15.7, 15.8 | 16 | 13 | 12 |
Quality assurance | 15.6 | 17 | — | 12 |
Funding and declaration and management of interests | ||||
Funding sources and roles of the funder | 7.6 | 18 | 22 | 7 |
Declaration and management of interests | 7 | 19 | 23 | 7 |
Other information | ||||
Access | 16.1 | 20 | — | Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) |
Suggestions for further research | 13.5 | 21 | — | Each recommendation (EtD) |
Limitations of the guideline | — | 22 | — | 15 |
Updating the guideline | 18 | — | 14 | 16 |
Applicability | 14.5 | 14 | 14 | Whole document (eg, feasibility, barriers for each recommendation) |
Implementation | 16 | — | 18, 19 | Each recommendation (EtD) & 16 (local adaptation) |
Monitoring | 17.3 | — | 21 | Each recommendation (EtD) |
Supplement 1; —, not addressed.